bullish
Otsuka 3Q FY18 (YE Dec'18) Results - First Glance
419 Views14 Nov 2018 23:38
Key highlights
While the pharmaceutical segment (~60% of total sales) stayed flat (+1.2% to ¥200b), the Nutraceutical business (~30% of total) grew...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Otsuka 3Q FY18 (YE Dec'18) Results - First Glance14 Nov 2018
- 1H FY18 In Line – Key Drivers Strong but Pipeline Potential Weak28 Aug 2018
- Rexulti (Brexpiprazole) – Serotonin-Dopamine Activity Modulator23 Jan 2017
x